Keywords: European Commission, EFPIA, Patient information, DG Sanco

EFPIA looks to new EU Commission line up to recognize Pharma contribution

Article | 2 December 2009

The European Federation of Pharmaceutical Industries and Associations (EFPIA) was not surprised by the move of responsibility for the pharmaceutical sector from Enterprise and Industry to the Health and Consumer (DG Sanco) portfolio at the European Commission, and it is not unwelcome, a spokesman told The Pharma Letter, following our report yesterday implying otherwise.

“It had been discussed widely in the margins and did not come as complete surprise. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in